4//SEC Filing
Zhan Hangjun 4
Accession 0001250853-21-000012
CIK 0001561743other
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 6:58 PM ET
Size
10.9 KB
Accession
0001250853-21-000012
Insider Transaction Report
Form 4
Zhan Hangjun
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2021-01-17+6,250→ 43,211 total - Tax Payment
Common Stock
2021-01-17$4.95/sh−3,385$16,756→ 39,826 total - Award
Stock Option (right to buy)
2021-01-20+83,500→ 83,500 totalExercise: $4.44Exp: 2031-01-19→ Common Stock (83,500 underlying) - Exercise/Conversion
Restricted Stock Units
2021-01-17−6,250→ 18,750 total→ Common Stock (6,250 underlying)
Footnotes (4)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]These shares are being surrendered to satisfy a tax withholding obligation of the reporting person.
- [F3]On January 17, 2020, the reporting person was granted 25,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
- [F4]The option will vest as to 25% after one year following the date of grant, and the remainder will vest in 36 equal monthly installments over the following three years.
Documents
Issuer
Kindred Biosciences, Inc.
CIK 0001561743
Entity typeother
Related Parties
1- filerCIK 0001719057
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 6:58 PM ET
- Size
- 10.9 KB